Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3533 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3287 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-01 | 2024-03-22 | 221096 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-08 | 2024-03-15 | 221717 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-06-20 | 2025-08-01 | 260830 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-06-20 | 2025-08-01 | 260833 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-06-20 | 2025-08-01 | 260836 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2025-06-20 | 2025-07-31 | 260839 |
| APO-METOPROLOL | 25MG | TABLET | Resolved | 2021-05-28 | 2021-06-28 | 140072 |
| APO-METOPROLOL | 100MG | TABLET | Resolved | 2023-05-19 | 2023-07-21 | 192791 |
| APO-METOPROLOL | 50MG | TABLET | Resolved | 2023-06-16 | 2023-07-21 | 195094 |
| APO-METOPROLOL | 25MG | TABLET | Resolved | 2023-10-20 | 2023-12-01 | 207728 |
| APO-METOPROLOL | 25MG | TABLET | Resolved | 2024-01-05 | 2024-03-22 | 215233 |
| APO-METOPROLOL | 50MG | TABLET | Resolved | 2024-04-05 | 2024-04-26 | 224595 |
| APO-METOPROLOL | 100MG | TABLET | Resolved | 2024-09-05 | 2025-01-03 | 236860 |
| APO-METOPROLOL | 50MG | TABLET | Resolved | 2024-10-24 | 2025-01-03 | 241087 |
| APO-METOPROLOL | 25MG | TABLET | Resolved | 2024-10-24 | 2025-01-03 | 241090 |
| APO-METOPROLOL | 50MG | TABLET | Resolved | 2025-05-15 | 2025-06-27 | 257415 |
| APO-METOPROLOL | 100MG | TABLET | Resolved | 2025-08-07 | 2025-10-10 | 264549 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2020-09-22 | 2020-11-23 | 124789 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2020-12-28 | 2021-02-09 | 130716 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2024-05-03 | 2024-06-28 | 227068 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |